eISSN: 2081-2841
ISSN: 1689-832X
Journal of Contemporary Brachytherapy
Current Issue Archive Supplements Articles in Press Journal Information Aims and Scope Editorial Office Editorial Board Register as Author Register as Reviewer Instructions for Authors Abstracting and indexing Subscription Advertising Information Links
SCImago Journal & Country Rank

vol. 11
Review paper

Current state of interventional radiotherapy (brachytherapy) education in Italy: results of the INTERACTS survey

Luca Tagliaferri, György Kovács, Cynthia Aristei, Vitaliana De Sanctis, Fernando Barbera, Alessio Giuseppe Morganti, Calogero Casà, Bradley Rumwell Pieters, Elvio Russi, Lorenzo Livi, Renzo Corvò, Andrea Giovagnoni, Umberto Ricardi, Vincenzo Valentini, Stefano Maria Magrini, Directors of the Italian Radiation Oncology Schools

J Contemp Brachytherapy 2019; 11, 1: 48–53
Online publish date: 2019/02/25
View full text
Get citation
JabRef, Mendeley
Papers, Reference Manager, RefWorks, Zotero
Increased complexity of interventional radiotherapy (brachytherapy – BT) treatment planning and quality control procedures has led to the need of a specific training. However, the details of the features of BT learning objectives and their distribution in the training paths of the Italian Radiation Oncology Schools are not known. This paper aims to provide the actual ‘state-of-the-art’ of BT education in Italy and to stimulate the debate on this issue.

Material and methods
All the Italian radiation oncology schools’ directors (SD) were involved in a web survey, which included questions on the teaching of BT, considering also the 2011 ESTRO core curriculum criteria. The survey preliminary results were discussed at the 8th Rome INTER-MEETING (INTERventional Radiotherapy Multidisciplinary Meeting), June 24th, 2017. The present paper describes the final results of the survey and possible future teaching strategies resulting from the discussion.

A total of 23 SDs answered the survey. The results evidenced a wide heterogeneity in the learning activities available to trainees in BT across the country. While theoretical knowledge is adequately and homogeneously transmitted to trainees, the types of practice to which they are exposed varies significantly among different schools.

This survey proves the need for an improvement of practical BT education in Italy and the advisability of a national BT education programme networking schools of different Universities. Beside the organization of national/international courses for BT practical teaching, Universities may also establish post-specialization courses (‘second level’ Masters) to allow professionals (already certified in radiation oncology) to acquire more advanced BT knowledge.


brachytherapy, teaching, interventional radiotherapy, survey

Han K, Milosevic M, Fyles A et al. Trends in the utilization of brachytherapy in cervical cancer in the United States. Int J Radiation Oncol Biol Phys 2013; 87: 111-119.
Hoskin PJ, Bownes P. Innovative technologies in radiation therapy: brachytherapy. Semin Radiat Oncol 2006; 16: 209-217.
Eriksen JG, Beavis AW, Coffey MA et al. The updated ESTRO core curricula 2011 for clinicians, medical physicists and RTTs in radiotherapy/radiation oncology. Radiother Oncol 2012; 103: 103-108.
Autorino R, Vicenzi L, Tagliaferri L et al. A national survey of AIRO (Italian Association of Radiation Oncology) brachytherapy (Interventional Radiotherapy) study group. J Contemp Brachytherapy 2018; 10: 254-259.
MIUR – D.L. n. 402/2017 Standard, requisiti e indicatori di attivita’ formativa e assistenziale delle Scuole di specializzazione di area sanitaria. (17A04639) (GU Serie Generale n.163 del 14-07-2017 - Suppl. Ordinario n. 38). http://www.gazzettaufficiale.it/eli/id/2017/07/14/17A04639/sg
14-7-2017 Supplemento ordinario n. 38 alla GAZZETTA UFFICIALE Serie generale - n. 163, Allegato 3. http://www.gazzettaufficiale.it/eli/gu/2017/07/14/163/so/38/sg/pdf
Tagliaferri L, Pagliara MM, Boldrini L et al. INTERACTS (INTErventional Radiotherapy ACtive Teaching School) guidelines for quality assurance in choroidal melanoma interventional radiotherapy (brachytherapy) procedures. J Contemp Brachytherapy 2017; 9: 287-295.
Kovács G, Tagliaferri L, Valentini V. Is an Interventional Oncology Center an advantage in the service of cancer patients or in the education? The Gemelli Hospital and INTERACTS experience. J Contemp Brachytherapy 2017; 9: 497-498.
Fellin G, Mirri MA, Santoro L et al. Low dose rate brachytherapy (LDR-BT) as monotherapy for early stage prostate cancer in Italy: practice and outcome analysis in a series of 2,237 patients from 11 institutions. Br J Radiol 2016; 89: 20150981.
Frakulli R, Buwenge M, Cammelli S et al. Brachytherapy boost after chemoradiation in anal cancer: a systematic review. J Contemp Brachytherapy 2018; 10: 246-253.
Lancellotta V, Kovács G, Tagliaferri L et al. Age is not a limiting factor in interventional radiotherapy (brachytherapy) for patients with localized cancer. Biomed Res Int 2018; 2018: 2178469.
Autorino R, Vicenzi L, Tagliaferri L et al. A national survey of AIRO (Italian Association of Radiation Oncology) brachytherapy (Interventional Radiotherapy) study group. J Contemp Brachytherapy 2018; 10: 254-259.
Blasi MA, Laguardia M, Tagliaferri L et al. Brachytherapy alone or with neoadjuvant photodynamic therapy for amelanotic choroidal melanoma: functional outcomes and local tumor control. Retina 2016; 36: 2205-2212.
Frakulli R, Galuppi A, Cammelli S et al. Brachytherapy in non-melanoma skin cancer of eyelid: a systematic review. J Contemp Brachytherapy 2015; 7: 497-502.
Tagliaferri L, Pagliara MM, Masciocchi C et al. Nomogram for predicting radiation maculopathy in patients treated with Ruthenium-106 plaque brachytherapy for uveal melanoma. J Contemp Brachytherapy 2017; 9: 540-547.
Tagliaferri L, Bussu F, Fionda B et al. Perioperative HDR brachytherapy for reirradiation in head and neck recurrences: single-institution experience and systematic review. Tumori 2017; 103: 516-524.
Aristei C, Maranzano E, Lancellotta V et al. Partial breast irradiation with interstitial multi-catheter high-dose-rate brachytherapy. Long-term results of a phase II prospective study. Radiother Oncol 2017; 124: 208-213.
Bussu F, Tagliaferri L, Mattiucci G et al. Comparison of interstitial brachytherapy and surgery as primary treatments for nasal vestibule carcinomas. Laryngoscope 2016; 126: 367-371.
Perrucci E, Lancellotta V, Bini V et al. Recurrences and toxicity after adjuvant vaginal brachytherapy in Stage I-II endometrial cancer: A monoinstitutional experience. Brachytherapy 2016; 15: 177-184.
De Sanctis V, Agolli L, Valeriani M et al. External-beam radiotherapy and/or HDR brachytherapy in postoperative endometrial cancer patients: clinical outcomes and toxicity rates. Radiol Med 2013; 118: 311-322.
Fuccio L, Mandolesi D, Farioli A et al. Brachytherapy for the palliation of dysphagia owing to esophageal cancer: A systematic review and meta-analysis of prospective studies. Radiother Oncol 2017; 122: 332-339.
Tagliaferri L, Bussu F, Rigante M et al. Endoscopy-guided brachytherapy for sinonasal and nasopharyngeal recurrences. Brachytherapy 2015; 14: 419-425.
Mattiucci GC, Autorino R, Tringali A et al. A phase I study of high-dose-rate intraluminal brachytherapy as palliative treatment in extrahepatic biliary tract cancer. Brachytherapy 2015; 14: 401-404.
Giannelli F, Chiola I, Belgioia L et al. Complete response in a patient with gynecological hidradenocarcinoma treated with exclusive external beam radiotherapy and brachytherapy: a case report. J Contemp Brachytherapy 2017; 9: 572-578.
Tagliaferri L, Manfrida S, Barbaro B et al. MITHRA – multiparametric MR/CT image adapted brachytherapy (MR/CT-IABT) in anal canal cancer: a feasibility study. J Contemp Brachytherapy 2015; 7: 336-345.
Autorino R, Mattiucci GC, Ardito F et al. Radiochemotherapy with gemcitabine in unresectable extrahepatic cholangiocarcinoma: long-term results of a phase ii study. Anticancer Res 2016; 36: 737-740.
Fuccio L, Guido A, Hassan C et al. Underuse of brachytherapy for the treatment of dysphagia owing to esophageal cancer. An Italian survey. Dig Liver Dis 2016; 48: 1233-1236.
Cortesi A, Galuppi A, Frakulli R et al. Adjuvant radiotherapy with brachytherapy boost in soft tissue sarcomas. J Contemp Brachytherapy 2017; 9: 256-262.
Barbera F, Triggiani L, Buglione M et al. Salvage low dose rate brachytherapy for recurrent prostate cancer after external beam radiotherapy: results from a single institution with focus on toxicity and functional outcomes. Clin Med Insights Oncol 2017; 11: 1179554917738765.
Pagliara MM, Tagliaferri L, Azario L et al. Ruthenium brachytherapy for uveal melanomas: Factors affecting the development of radiation complications. Brachytherapy 2018; 17: 432-438.
Perrucci E, Lancellotta V, Bini V et al. Quality of life and cosmesis after breast cancer: whole breast radiotherapy vs partial breast high-dose-rate brachytherapy. Tumori 2015; 101: 161-167.
Haie-Meder C, Siebert FA, Pötter R. Image guided, adaptive, accelerated, high dose brachytherapy as model for advanced small volume radiotherapy. Radiother Oncol 2011; 100: 333-343.
Niehoff P, Dietrich J, Ostertag H et al. High-dose-rate (HDR) or pulsed-dose-rate (PDR) perioperative interstitial intensity-modulated brachytherapy (IMBT) for local recurrences of previously irradiated breast or thoracic wall following breast cancer. Strahlenther Onkol 2006; 182: 102-107.
Williamson JF. Current brachytherapy quality assurance guidance: does it meet the challenges of emerging image-guided technologies? Int J Radiat Oncol Biol Phys 2008; 71: S18-22.
Doniec JM, Schniewind B, Kovács G et al. Multimodal therapy of anal cancer added by new endosonographic-guided brachytherapy. Surg Endosc 2006; 20: 673-678.
Kirchheiner K, Nout RA, Tanderup K et al. Manifestation pattern of early-late vaginal morbidity after definitive radiation (chemo)therapy and image-guided adaptive brachytherapy for locally advanced cervical cancer: an analysis from the EMBRACE study. Int J Radiat Oncol Biol Phys 2014; 89: 88-95.
Kirisits C, Federico M, Nkiwane K et al. Quality assurance in MR image guided adaptive brachytherapy for cervical cancer: Final results of the EMBRACE study dummy run. Radiother Oncol 2015; 117: 548-554.
Nkiwane KS, Pötter R, Tanderup K et al. Single line source with and without vaginal loading and the impact on target coverage and organ at risk doses for cervix cancer Stages IB, II, and IIIB: treatment planning simulation in patients treated with MRI-guided adaptive brachytherapy in a multicentre study (EMBRACE). Brachytherapy 2013; 12: 317-323.
Pötter R, Tanderup K, Kirisits C et al. The EMBRACE II study: The outcome and prospect of two decades of evolution within the GEC-ESTRO GYN working group and the EMBRACE studies. Clin Transl Radiat Oncol 2018; 9: 48-60.
Sturdza A, Pötter R, Fokdal LU et al. Image guided brachytherapy in locally advanced cervical cancer: Improved pelvic control and survival in RetroEMBRACE, a multicenter cohort study. Radiother Oncol 2016; 120: 428-433.
Fokdal L, Sturdza A, Mazeron R et al. Image guided adaptive brachytherapy with combined intracavitary, and interstitial technique improves the therapeutic ratio in locally advanced cervical cancer: Analysis from the retroEMBRACE study. Radiother Oncol 2016; 120: 434-440.
Rodda S, Morris WJ, Hamm J et al. ASCENDE-RT: An analysis of health-related quality of life for a randomized trial comparing low-dose-rate brachytherapy boost with dose-escalated external beam boost for high- and intermediate-risk prostate cancer. Int J Radiat Oncol Biol Phys 2017; 98: 581-589.
Rodda S, Tyldesley S, Morris WJ et al. ASCENDE-RT: An analysis of treatment-related morbidity for a randomized trial comparing a low-dose-rate brachytherapy boost with a dose-escalated external beam boost for high- and intermediate-risk prostate cancer. Int J Radiat Oncol Biol Phys 2017; 98: 286-295.
Polgár C, Van Limbergen E, Pötter R et al. GEC-ESTRO breast cancer working group. Patient selection for accelerated partial-breast irradiation (APBI) after breast-conserving surgery: recommendations of the Groupe Européen de Curiethérapie-European Society for Therapeutic Radiology and Oncology (GEC-ESTRO) breast cancer working group based on clinical evidence (2009). Radiother Oncol 2010; 94: 264-273.
Armpilia C, Dale RG, Sandilos P et al. Radiobiological modelling of dose-gradient effects in low dose rate, high dose rate and pulsed brachytherapy. Phys Med Biol 2006; 51: 4399-4411.
Joslin CAF, Flynn A, Hall EJ. Principles and practice of brachytherapy using afterloading systems. London, Arnold, 2001.
Mould RF, Batterman JJ, Martinez AA et al. Brachytherapy from radium to optimization. Nucletron International BV, Veenendaal, The Netherlands 1994.
Lievens Y, De Schutter H, Stellamans KP et al. Radiotherapy access in Belgium: How far are we from evidence-based utilization? Eur J Cancer 2017; 84: 102-113.
Quick links
© 2019 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe